Clinical Utility of Rush Venom Immunotherapy: Current Status
Vianney Gruzelle,1 Claire Mailhol,2,3 David W Waters,4 Laurent Guilleminault2,4 1Department of Paediatric Pneumology and Allergology, University Hospital Centre of Toulouse, Toulouse, France; 2Department of Respiratory Medicine and Allergic Diseases, University Hospital Centre of Toulouse, Toulouse,...
Main Authors: | Gruzelle V, Mailhol C, Waters DW, Guilleminault L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-utility-of-rush-venom-immunotherapy-current-status-peer-reviewed-article-JAA |
Similar Items
-
Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush
by: Ali Selcuk, et al.
Published: (2022-12-01) -
Hymenoptera Venom Immunotherapy in Dogs: Safety and Clinical Efficacy
by: Ana Rostaher, et al.
Published: (2023-09-01) -
Venom immunotherapy in indolent systemic mastocytosis with high serum tryptase level
by: Ali Selcuk, et al.
Published: (2021-06-01) -
Simultaneous Influenza Vaccination and Hymenoptera Venom Immunotherapy Is Safe
by: Ewa Czerwińska, et al.
Published: (2021-04-01) -
Venom immunotherapy protocols in the pediatric population: how to choose?
by: Francesca Saretta, et al.
Published: (2023-09-01)